Laquinimod Study in Active Crohn's Disease

Study Title

Laquinimod Phase IIa Study in Active Crohn's Disease

Teva Identifier

CD-LAQ-201

ClinicalTrials.gov Identifier

NCT00737932

Study Status

Completed

Trial Condition(s)

Crohn's Disease

Interventions

Drug: Laquinimod | Other: placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
inflammation and infections icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 75 Years

Trial Duration

05/01/2010 - 12/01/2011

Phase

Phase 2

Study Type

Interventional